Emergent Health Corp
EMGE · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | -$0 | $0 | $0 |
| % Growth | 100% | -200% | 37.8% | – |
| Cost of Goods Sold | $0 | -$0 | $0 | $0 |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | 62.9% | 62.9% | 51.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | -$0 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | -$0 | $1 | $0 |
| Operating Income | -$0 | $0 | -$0 | -$0 |
| % Margin | – | -32.6% | -76.3% | -54.3% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | $0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | – | -19.7% | -89.8% | -76.8% |
| EPS | -0 | 0 | -0.001 | -0.001 |
| % Growth | -200% | 120% | -66.7% | – |
| EPS Diluted | -0 | 0 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 427 | 427 | 427 | 427 |
| Weighted Avg Shares Out Dil | 427 | 500 | 427 | 427 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | -$0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | – | -33.7% | -75.2% | -53.2% |